Monday, June 8, 2026

10:45 AM - 11:45 AM

Salon A

---

Overview

Dr. Kathleen Pajer

---

Details

At the end of this session , participants will be able to: 1. Identify updated assessment strategies that improve diagnostic accuracy across age groups and improve access care. 2. Describe the latest updates in ADHD pharmacology and their incorporation into CADDRA guidelines, including changes to first-line medications and prescribing considerations. 3. Apply evidence-based recommendations from the updated guidelines to enhance clinical decision-making in everyday practice.